NEW YORK (Reuters Health) – Suppressive therapy with corticosteroids and antihistamines is effective for managing clopidogrel hypersensitivity in the majority of cases, allowing antiplatelet therapy to continue uninterrupted,…
NEW YORK (Reuters Health) – Among patients with myeloma treated with thalidomide, antithrombotic prophylactic therapies with aspirin, warfarin or enoxaparin reduce thromboembolic events to a similar degree, according…
NEW YORK (Reuters Health) – A new study questions the “universal definition” of percutaneous coronary intervention (PCI)-related myocardial infarction (MI type 4a) — an increase of the biomarkers…
NEW YORK (Reuters Health) – In the emergency department, successful intubation on the first try is equally likely using either succinylcholine at a median dose of 1.65 mg/kg…
NEW YORK (Reuters Health) – Premature infants of < 34 weeks’ gestation on respiratory support should not be treated with inhaled nitric oxide, according to a new consensus…
Doctors often prescribe unfractionated heparin to obese patients with venous thromboembolism below the recommended doses based on body weight, according to a new study. As a result, some…
NEW YORK (Reuters Health) – Patients with pneumonia and blood oxygen saturation less than 90% are usually hospitalized. Yet, results of new study suggest that the threshold for…
NEW YORK (Reuters Health) – The authors of a systematic review and meta-analysis of relevant studies encourage clinicians to exercise good judgment in using the injectable antibiotic tigecycline…
NEW YORK (Reuters Health) – Anticoagulation with low-molecular-weight heparin (LMWH) dalteparin following heart valve surgery leads to fewer adverse events than does unfractionated heparin, Canadian researchers report in…
NEW YORK (Reuters Health) – Recombinant surfactant protein C based surfactant (rSP-C, Nycomed) provides no benefit in patients with severe direct lung injury, but the information gained may…